ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLUE Monte Rosa Therapeutics Inc

3.66
-0.28 (-7.11%)
Last Updated: 19:55:30
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000001.06M
Operating Income -27.23M-28.36M-32.49M-34.26M-37.22M-36.97M-34.86M-34.95M
Pre Tax Income -26.47M-27.32M-30.78M-32.04M-34.99M-34.71M-33.27M-31.89M
Net Income -26.36M-27.32M-30.78M-32.04M-35.18M-34.88M-33.25M-31.97M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -27.23M-28.38M-32.49M-34.26M-37.2M-36.97M-34.86M-34.95M
EBITDA -26.39M-27.33M-31.42M-33.11M-35.83M-35.13M-33.04M-33.05M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -7.99M-28.01M-72.88M-112.38M-143.31M
Pre Tax Income -7.74M-35.88M-73.96M-108.5M-135.01M
Net Income -7.74M-35.88M-73.96M-108.5M-135.35M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -5.466-21.281-1.589-2.2-2.699
EBIT -7.72M-35.69M-73.84M-112.28M-143.29M
EBITDA -7.92M-27.47M-70.75M-108.64M-137.11M

Your Recent History